Sphera Funds Management Ltd. 13D and 13G filings for Chemomab Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 5:25 pm Sale |
2025-03-31 | 13G | Chemomab Therapeutics Ltd. CMMB |
Sphera Funds Management Ltd. | 900,428 4.780% |
-314,147 (-25.86%) |
Filing |
| 2024-08-20 2:36 pm Purchase |
2024-07-25 | 13G | Chemomab Therapeutics Ltd. CMMB |
Sphera Funds Management Ltd. | 1,214,575 6.560% |
1,214,575 (New Position) |
Filing |